Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;6(1):143-51.
doi: 10.3233/JPD-150691.

An Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials

Affiliations
Free PMC article

An Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials

Luc Bousset et al. J Parkinsons Dis. 2016.
Free PMC article

Abstract

Background: Preformed α-synuclein fibrils seed the aggregation of soluble α-synuclein in cultured cells and in vivo. This, and other findings, has kindled the idea that α-synuclein fibrils possess prion-like properties.

Objective: As α-synuclein fibrils should not be considered as innocuous, there is a need for decontamination and inactivation procedures for laboratory benches and non-disposable laboratory material.

Methods: We assessed the effectiveness of different procedures designed to disassemble α-synuclein fibrils and reduce their infectivity. We examined different commercially available detergents to remove α-synuclein assemblies adsorbed on materials that are not disposable and that are most found in laboratories (e.g. plastic, glass, aluminum or stainless steel surfaces).

Results: We show that methods designed to decrease PrP prion infectivity neither effectively remove α-synuclein assemblies adsorbed to different materials commonly used in the laboratory nor disassemble the fibrillar form of the protein with efficiency. In contrast, both commercial detergents and SDS detached α-synuclein assemblies from contaminated surfaces and disassembled the fibrils.

Conclusions: We describe three cleaning procedures that effectively remove and disassemble α-synuclein seeds. The methods rely on the use of detergents that are compatible with most non-disposable tools in a laboratory. The procedures are easy to implement and significantly decrease any potential risks associated to handling α-synuclein assemblies.

Keywords: Alpha synuclein; Parkinson’s disease; cleaning procedures; detergent; fibrils; inactivation; removal.

PubMed Disclaimer

Figures

Fig.1
Fig.1
Efficiency of different cleaning solutions to remove α-Syn assemblies from different surfaces. Quantification of the remaining Atto-550 labeled oligomeric, A, α-Syn fibrils, B and α-Syn ribbons, C, spotted and dried on plastic, glass, aluminum and stainless steel surfaces, previously scraped with sandpaper, using a fluorescence imager after cleaning with the different solutions. Error bars represent standard error (SE) (n = 4 independent measurements) performed in quadruplicates. The measured fluorescence data from imaging are presented as averages±standard error in Supplementary Table 1, panels A, B, C and C’.
Fig.2
Fig.2
Quantitative assessment of the fraction of fibrillar α-Syn solubilized in the different cleaning solutions. The fraction (%) of α-Syn fibrils, A and ribbons, B, that becomes soluble relative to the initial total amount of fibrillar α-Syn in the cleaning solution was determined following ultracentrifugation by measurement of the absorbance of fluorescently labeled α-Syn in the supernatant fraction as described in the material and methods section. Error bars represent standard error (SE) (n = 4 independent measurements) performed in quadruplicates. The measured absorbance data are presented as averages±standard error in Supplementary Table 1, panels D and E.

References

    1. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, & Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature, 388, 839–840. - PubMed
    1. Gai WP, Power JH, Blumbergs PC, & Blessing WW (1998) Multiple-system atrophy: A new alpha-synuclein disease? Lancet, 352, 547–548. - PubMed
    1. Newell KL, Boyer P, Gomez-Tortosa E, Hobbs W, Hedley-Whyte ET, Vonsattel JP, & Hyman BT (1999) Alpha-synuclein immunoreactivity is present in axonal swellings in neuroal dystrophy and acute traumatic brain injury. J Neuropathol Exp Neurol, 58, 1263–1268. - PubMed
    1. Goldberg MS, & Lansbury PT Jr. (2000) Is there a cause-andeffect relationship between a-synuclein fibrilization and Parkinson’s disease? Nat Cell Biol, 2, E115–E119. - PubMed
    1. Uversky VN, Li J, Souillac P, Millett IS, Doniach S, Jakes R, Goedert M, & Fink AL (2002) Biophysical properties of the synucleins and their propensities to fibrillate: Inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem, 277, 11970–11978. - PubMed

Publication types